EDGAR Filing Documents for 0001193125-10-249246

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-10-249246

Filing Date

2010-11-05

Accepted

2010-11-05 09:16:44

Documents

Period of Report

2010-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	d10q.htm	10-Q	708978
2	4TH AMENDMENT DATED 9/3/10 TO LEASE AGREEMENT BETWEEN BRANDYWINE GRANDE AND PPD	dex10276.htm	EX-10.276	39572
3	SECTION 302 CEO CERTIFICATION	dex311.htm	EX-31.1	9740
4	SECTION 302 CFO CERTIFICATION	dex312.htm	EX-31.2	9746
5	SECTION 906 CEO CERTIFICATION	dex321.htm	EX-32.1	3498
6	SECTION 906 CEO CERTIFICATION	dex322.htm	EX-32.2	3507
12	GRAPHIC	g110299ex10_276pg004.jpg	GRAPHIC	70407
	Complete submission text file	0001193125-10-249246.txt		3285547

Data Files

Seq	Description	Document	Type	Size
7	XBRL INSTANCE DOCUMENT	ppdi-20100930.xml	EX-101.INS	490222
8	XBRL TAXONOMY EXTENSION SCHEMA	ppdi-20100930.xsd	EX-101.SCH	18223
9	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	ppdi-20100930_cal.xml	EX-101.CAL	40802
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	ppdi-20100930_lab.xml	EX-101.LAB	129427
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	ppdi-20100930_pre.xml	EX-101.PRE	79499

Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401

Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081

PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)